Zobrazeno 1 - 10
of 14
pro vyhledávání: '"J Nazco Casariego"'
Autor:
L Ramos Lopez, R Ramos-Díaz, I Alonso-Abreu, I Mourani-Padron, M Carrillo-Palau, M C Reygosa, S Medina-Chico, F Gutierrez-Nicolas, G J Nazco-Casariego, M Hernandez-Guerra
Publikováno v:
Journal of Crohn's and Colitis. 17:i644-i644
Background Therapeutic drug monitoring (TDM) is a valuable tool to optimize anti-TNF biologics in inflammatory bowel disease (IBD). However, for the non-anti-TNF agents (such as Ustekinumab-UST- an anti-IL12/23) TDM value and evidence in real-world I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac8c90e0a254af81605045b60e304f48
https://doi.org/10.1093/ecco-jcc/jjac190.0647
https://doi.org/10.1093/ecco-jcc/jjac190.0647
Autor:
M. Pérez Campos, J Nazco Casariego, N Yurrebaso Eguior, M Bullejos Molina, S. González Ponsjoan, C Romero Delgado, G Calzado Gómez, T. Virgós Aller
Publikováno v:
Eur J Hosp Pharm
Background The commercialisation of fixed-dose combination meant an improvement in antiretroviral therapy (ART). With generics we have the opportunity to maintain the therapy at a lower cost, but we complicate the dosage regimen again. Purpose To ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fab780a626c1b55531c3381281534838
https://europepmc.org/articles/PMC7535606/
https://europepmc.org/articles/PMC7535606/
Autor:
S García Gil, V Casañas-Sánchez, MM Viña Romero, F Gutiérrez Nicolás, J Nazco Casariego, GA González de la Fuente, R Ramos-Díaz
Publikováno v:
Pharmacokinetics and pharmacodynamics.
Background Thiopurines are widely used in different treatments. However, exposure to this drug can cause toxicity in the patient due to polymorphisms in the gene coding NUDT15, an enzyme involved in the metabolic activity of thiopurines. Carriers of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d35c4f50fff13a8dc63575a088bf28d
https://doi.org/10.1136/ejhpharm-2017-000640.433
https://doi.org/10.1136/ejhpharm-2017-000640.433
Autor:
J Nazco Casariego, G Calzado Gómez, M Suarez Gonzalez, M Bullejos Molina, N Roman Gonzalez, C Romero Delgado
Publikováno v:
Drug information and pharmacotherapy.
Background In recent years, new drugs have been approved for metastatic melanoma. The BRAF gene is the most common mutation in cutaneous melanomas and is present in 50% of melanomas. Vemurafenib and dabrafenib are used for the treatment of adult pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e48a4faadbe47e3cb805daf050b35d3
https://doi.org/10.1136/ejhpharm-2017-000640.277
https://doi.org/10.1136/ejhpharm-2017-000640.277
Autor:
N Batista-López, J González-García, G J Nazco-Casariego, F Guttiérrez-Nicolás, B Alonso-Alvarez
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 23(8)
Introduction The use of trastuzumab with a fluoropyrimidine and platinum compound is currently the standard first-line treatment of patients with metastatic HER2-positive gastric cancer, but it appears that serum levels of trastuzumab determine the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7339f510ca3c3d506bf0c8906894cc07
https://pubmed.ncbi.nlm.nih.gov/27664112
https://pubmed.ncbi.nlm.nih.gov/27664112
Autor:
I González Perera, J Nazco Casariego, M Suarez Gonzalez, J González García, G Calzado Gómez, M Bullejos Molina, C Romero Delgado
Publikováno v:
European Journal of Hospital Pharmacy. 23:A147.2-A148
Background Teriflunomide is an immunomodulatory agent with anti-inflammatory properties that inhibits the mitochondrial enzyme dehidroorotato-dehydrogenase (DHO-DH), which is required for the synthesis of pyrimidine, blocking the proliferation of act
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::941650325abca3830cc00144ecf2233b
https://doi.org/10.1136/ejhpharm-2016-000875.333
https://doi.org/10.1136/ejhpharm-2016-000875.333
Autor:
J Nazco Casariego, G Calzado Gómez, C Romero Delgado, I Perera Gonzalez, J González García, M Bullejos Molina, M Suarez Delgado
Publikováno v:
European Journal of Hospital Pharmacy. 23:A144.1-A144
Background Multiple sclerosis (MS) is a chronic and inflammatory neurological disease in which focal demyelination occurs in the CNS. Dimethyl fumarate (DMF) is indicated for the treatment of adult patients with relapsing-remitting multiple sclerosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d7d6ddee775add8fa758039a902dc74
https://doi.org/10.1136/ejhpharm-2016-000875.325
https://doi.org/10.1136/ejhpharm-2016-000875.325
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J Nazco Casariego, GA González de la Fuente, M Bullejos Molina, J González García, F Gutiérrez Nicolás, I González Perera
Publikováno v:
European Journal of Hospital Pharmacy. 22:A209.1-A209
Background In recent years, simplification of antiretroviral therapy is increasingly being recognised as an attractive therapeutic alternative for cost minimization. Currently, this kind of treatment is used in patients without a prior history of fai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d95aa903d233395e1eb83576df022ec
https://doi.org/10.1136/ejhpharm-2015-000639.512
https://doi.org/10.1136/ejhpharm-2015-000639.512
Autor:
M Bullejos Molina, J González García, I González Perera, J Nazco Casariego, I Rodriguez Pedrosa
Publikováno v:
European Journal of Hospital Pharmacy. 20:A118.3-A119
Background Daptomycin is an antibiotic only active against Gram-positive bacteria, with rapid bactericidal activity, a concentration-dependent and post-antibiotic effect. Indicated for complicated skin or soft tissue infections in adults (cSSTI), rig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08f71b86ffc6c4b99fd54a0066a8c79e
https://doi.org/10.1136/ejhpharm-2013-000276.329
https://doi.org/10.1136/ejhpharm-2013-000276.329